Molecular Partners Reports Corporate Highlights and Key Financials for H1 2021

NEXT STORY
Saniona publicerar sin delårsrapport för det andra kvartalet 2021
PREV STORY
HUTCHMED Initiates a Phase Ib/II Trial of Fruquintinib in Combination with Tislelizumab in Advanced Triple Negative Breast Cancer or Advanced Endometrial Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

“Risky, dangerous” changes being proposed for emergency medical response by Ontario Liberals, say CUPE paramedics

TORONTO, ONTARIO--(Marketwired - June 5, 2017) - Diverting and triaging patients who call 911 ...

author_avatar
NASDAQ Market News

VBL Therapeutics to Report Second Quarter 2018 Financial Results on August 16

TEL AVIV, Israel, Aug. 01, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage ...

author_avatar
NASDAQ Market News

Molecular Templates to Present at the 2017 BIO Investor Forum

AUSTIN, Texas, Oct. 06, 2017 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical ...

author_avatar
NASDAQ Market News